A double-blind parallel-group dose-titration study comparing a fentanyl-containing patch formulated for 1-day application for the treatment of cancer pain with Durotep® MT patch

Japanese Journal of Anesthesiology

Volumn 60, Issue 2, 2011, Pages 157-167

  Hanaoka, Kazuo ^a,b   Yoshimura, Takashi ^a,b   Tomioka, Tomoyasu ^a,b   Sakata, Hideo ^a,b  

^a JR Tokyo General Hospital   (Japan)

^b Janssen Pharmaceutical KK   (Japan)

Author keywords

1 day formulation; Cancer pain; Fentanyl; Transdermal formulation

Indexed keywords

FENTANYL;

ARTICLE; CANCER PAIN; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG DOSE TITRATION; DRUG EFFICACY; DRUG FORMULATION; DRUG SAFETY; HUMAN; TRANSDERMAL PATCH;

ADMINISTRATION, CUTANEOUS; AGED; ANALGESICS, OPIOID; DOSAGE FORMS; DOUBLE-BLIND METHOD; FEMALE; FENTANYL; HUMANS; MALE; MIDDLE AGED; NEOPLASMS; PAIN, INTRACTABLE; TREATMENT OUTCOME;

EID: 79952302395     PISSN: 00214892     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Kokubun H, Matoba M, Hoka S, Yamada Y, Yago K. Relationship between serum fentanyl concentration and transdermal fentanyl dosage, and intraindividual variability in fentanyl concentration after application of fentanyl patches in patients with cancer pain. 2007 ; 33 : 200-5.
2. Freynhagen R, von Giesen HJ, Busche P, Sabatowski R, Konrad C, Grand S. Switching from reservoir to matrix systems for the transdermal delivery of fentanyl : a prospective, multicenter pilot study in outpatients with chronic pain. J Pain Symptom Manage 2005 ; 30 : 289-97. (Pubitemid 41354935)